Department of Gynecology and Obstetrics, The Fourth People's Hospital of Liaocheng, City, Shandong Province, Liaocheng, China.
Department of Gynecology and Obstetrics, Liaocheng People's Hospital, Liaocheng City, Shandong Province, China.
World J Surg Oncol. 2020 May 30;18(1):115. doi: 10.1186/s12957-020-01881-0.
MiR-125 has been shown to be involved in a variety of cancers, including cervical cancer (CC). Here, our goal was to explore miR-125 functional role and molecular mechanism in cervical cancer development and progression.
qRT-PCR was employ to detect miR-125 and VEGF mRNA expression. Western blot was applied for testing protein levels (VEGF, E-cadherin, N-cadherin, vimentin, AKT, p-AKT, PI3K, and p-PI3K). MTT and transwell assays were used for detecting cervical cancer cell progression, including cell viability, migration, and invasion.
We observed that miR-125 was downregulated, whereas VEGF was upregulated in cervical cancer tissues and cell lines (CaSki and SiHa). MiR-125 inhibited the proliferation, invasion, and migration by targeting VEGF in cervical cancer. Moreover, miR-125 negatively regulated VEGF expression in cervical cancer tissues. Finally, we demonstrated that miR-520d-5p inhibited the activation of PI3K/AKT signaling pathway.
In conclusion, the findings demonstrated that miR-125 inhibited cervical cancer progression and development by suppression VEGF and PI3K/AKT signaling pathway.
miR-125 已被证明参与多种癌症,包括宫颈癌(CC)。在这里,我们的目标是探讨 miR-125 在宫颈癌发生和发展中的功能作用和分子机制。
采用 qRT-PCR 检测 miR-125 和 VEGF mRNA 表达。Western blot 用于检测蛋白水平(VEGF、E-cadherin、N-cadherin、vimentin、AKT、p-AKT、PI3K 和 p-PI3K)。MTT 和 Transwell 检测用于检测宫颈癌细胞的进展,包括细胞活力、迁移和侵袭。
我们观察到 miR-125 在宫颈癌组织和细胞系(CaSki 和 SiHa)中下调,而 VEGF 上调。miR-125 通过靶向 VEGF 抑制宫颈癌的增殖、侵袭和迁移。此外,miR-125 负调控宫颈癌组织中 VEGF 的表达。最后,我们证明 miR-520d-5p 抑制了 PI3K/AKT 信号通路的激活。
综上所述,研究结果表明 miR-125 通过抑制 VEGF 和 PI3K/AKT 信号通路抑制宫颈癌的进展和发展。